GlaxoSmithKline Oy is a limited company based in Helsinki, registered in 1970. Its taxable income in 2024 was 3,0 M€ and its income taxes 613 t€. Public buyers bought 33,7 M€ from it in 2022–2026; the largest buyer is Terveyden ja hyvinvoinnin laitos (Sosiaali- ja terveysministeriön hallinnonala). It has won 2 public contracts in EU procurement notices.
Taxes
Measured by taxable income, GlaxoSmithKline Oy is in the top quarter of the industry class wholesale of pharmaceutical goods (82 companies with taxable income; median 603 t€, 5,1 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026. Revenue, financial ratios and employee numbers are shown once the company has filed its financial statements digitally.
Sales to public buyers
Largest buyers
Public contracts won
- Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031)Ministry of Social Affairs and Health2,6 M€
- Lääkkeiden erillishankinnat Itä-Suomen yhteistyöalueelle, syksy 2025Sansia Oy, Pohjois-Savon hyvinvointialue, Etelä-Savon hyvinvointialue, Pohjois-Karjalan hyvinvointialue, Keski-Suomen hyvinvointialue1,8 M€
Follow companies in your area
New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.
Try for free